Veterinary Vaccines Market to Reach USD 236 Million by 2031 | CAGR 8.4% | North America Leads with 32% Share | Key Players: Merck & Co., Zoetis, Boehringer Ingelheim, Biogénesis Bagó, Elanco

The global veterinary vaccines market reached US$124 million in 2023 and is projected to grow to US$236 million by 2031, expanding at a CAGR of 8.4% during the forecast period 2024-2031. Veterinary vaccines are biological preparations designed to provide immunity against specific animal diseases, playing a vital role in enhancing animal health, controlling the spread of zoonotic infections, and improving productivity in milk, meat, eggs, wool, and other animal-derived products. The market growth is driven by several factors, including increasing government initiatives to promote vaccination programs, rising demand for animal-derived food products, a growing prevalence of livestock diseases, and heightened awareness among animal owners regarding the benefits of vaccination. These dynamics collectively support the sustained expansion of the veterinary vaccines market worldwide.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):-https://www.datamintelligence.com/download-sample/veterinary-vaccines-market?Juli

Recent Developments:

✅ January 2026: A leading animal health company launched a novel multivalent livestock vaccine targeting simultaneous protection against major bacterial and viral diseases, enhancing herd immunity with reduced dosing frequency.

✅ November 2025: A global veterinary biotech firm introduced an mRNA‐based vaccine platform for rapid development and deployment of customized vaccines against emerging animal pathogens.

✅ September 2025: Major vaccine manufacturers expanded production capacity at state‐of‐the‐art biomanufacturing facilities, reducing lead times and strengthening global supply chains for veterinary immunization programs.

✅ June 2025: A research consortium completed successful field trials of a next‐generation poultry vaccine that significantly reduces mortality and improves growth performance in high‐density production environments.

✅ March 2025: Veterinary vaccine developers partnered with a digital health company to launch a vaccine tracking and cold‐chain monitoring solution, improving immunization coverage, compliance, and data visibility for livestock vaccination programs.

Buy Now & Unlock 360° Market Intelligence:-https://www.datamintelligence.com/buy-now-page?report=veterinary-vaccines-market?Juli

Key Players:

• Merck & Co., Inc - Holds a 16.2% share, driven by its broad portfolio of livestock and companion animal vaccines, including innovative biologics and recombinant products.

• Zoetis Services LLC - Holds a 14.5% share, fueled by its global reach in companion animal vaccines and integrated veterinary solutions.

• Boehringer Ingelheim International GmbH - Holds a 12.8% share, supported by extensive R&D in preventive vaccines and regional expansion in emerging markets.

• Biogénesis Bagó - Holds a 10.7% share, driven by strong presence in livestock vaccines and focus on disease prevention programs in Latin America.

• Elanco - Holds a 9.9% share, supported by its diversified vaccine portfolio and strategic partnerships for product innovation.

• Ceva - Holds an 8.6% share, fueled by its focus on poultry and livestock vaccines, alongside active expansion in emerging regions.

• HESTER BIOSCIENCES LIMITED - Holds a 7.4% share, driven by its strong domestic presence in India and veterinary immunization solutions.

• Phibro Animal Health Corporation - Holds a 6.5% share, supported by its combination of conventional and innovative vaccines for livestock.

• Indian Immunologicals Ltd - Holds a 5.8% share, focusing on government contracts and large-scale livestock vaccination programs in India.

• CZ Vaccines - Holds a 4.6% share, driven by its targeted R&D in animal health vaccines and expansion in select international markets.

Market Segmentation:

By Vaccines
Livestock Vaccines account for approximately 62% of the market, driven by rising demand for disease prevention in cattle, poultry, and swine, as well as government-supported immunization programs in emerging economies. Companion Animal Vaccines represent around 38%, fueled by increasing pet ownership, rising awareness of preventive care, and the launch of innovative vaccines targeting dogs and cats.

By Type
Live Attenuated Vaccines contribute about 28% of the market, preferred for strong and long-lasting immunity. Inactivated Vaccines hold 22%, widely used for safety in sensitive animal populations. Toxoid Vaccines account for 12%, mainly in livestock to prevent bacterial toxin-related diseases. Subunit and Recombinant Vaccines together make up 18%, reflecting innovation in targeted immunization with minimal side effects. Other Technologies, including DNA and vector vaccines, represent 20%, driven by R&D investments in next-generation vaccine platforms.

By Route of Administration
Injection Vaccines dominate with 67% share, as they are standard for both livestock and companion animals. Oral Vaccines account for 21%, primarily used in poultry and swine for ease of mass administration. Intranasal/Spray Vaccines hold 12%, gaining traction for respiratory disease prevention and stress-free delivery methods in both livestock and companion animals.

By Distribution Channel
Veterinary Hospitals represent 35% of the market, driven by specialized services and advanced immunization procedures. Veterinary Clinics contribute 40%, as they provide accessible vaccination for companion animals and small-scale livestock operations. Retail Pharmacies account for 25%, growing due to over-the-counter availability of companion animal vaccines and pet owner convenience, especially in urban regions.

Speak to Our Analyst and Get Customization in the report as per your requirements:-https://www.datamintelligence.com/customize/veterinary-vaccines-market?Juli

Regional Insights:

North America holds the largest share at approximately 32% of the global veterinary vaccines market. The region benefits from high pet ownership, strong adoption of preventive healthcare for animals, and the presence of leading vaccine manufacturers like Zoetis and Merck & Co., Inc. Government regulations and robust veterinary infrastructure further support market growth.

Europe accounts for around 28% of the market. Growth is driven by stringent livestock disease control regulations, increasing awareness of companion animal health, and widespread adoption of advanced vaccines, including recombinant and subunit technologies. Countries such as Germany, France, and the UK are key contributors.

Asia-Pacific represents roughly 25% of the market, emerging as the fastest-growing region due to expanding livestock production, rising disposable income, and increased pet ownership. Government initiatives in countries like China, India, and Japan to prevent livestock epidemics and improve animal welfare are boosting demand for vaccines.

Latin America holds about 10% of the market. The growth is supported by the large livestock sector, particularly in Brazil and Argentina, and increasing awareness of animal disease prevention. Investments in veterinary healthcare infrastructure and vaccine distribution are accelerating market expansion.

Market Dynamics:

Drivers:
The global veterinary vaccines market is primarily driven by increasing government initiatives aimed at improving animal health, ensuring food safety, and preventing the transmission of zoonotic diseases. Governments and animal welfare organizations worldwide are promoting vaccination programs through funding, awareness campaigns, and strategic immunization drives. For example, in September 2023, under the Foot-and-Mouth Disease (FMD) vaccine program, the government allocated over 13,000 crores to vaccinate 100% of cattle, buffalo, sheep, goats, and pigs, aiming to eradicate FMD by 2030. Similarly, in June 2022, India's Union Minister of Agriculture & Farmers' Welfare launched animal vaccines and diagnostic kits developed by the ICAR-National Research Center on Equines, highlighting government focus on equine health. Additionally, platforms like the Nandi portal, launched in June 2023, streamline approvals for veterinary drugs and vaccines, while regional immunization campaigns, such as those initiated by the Department of Animal Husbandry in Chandigarh to control lumpy skin disease, further boost market demand. These initiatives collectively drive adoption of veterinary vaccines across livestock and companion animals, expanding market growth opportunities globally.

Restraints:
Despite strong growth drivers, several factors limit the market's expansion. High storage and maintenance costs of vaccines, complex manufacturing processes, limited availability of advanced vaccine technologies, and stringent regulatory requirements pose significant challenges. Additionally, potential side effects of certain vaccines and the high cost of research and development (R&D) add further barriers for both manufacturers and end-users. These constraints can slow adoption, particularly among small-scale livestock farmers and in regions with limited veterinary infrastructure.

📌 Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription

☛ Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape

✅ Sustainability Impact Analysis

✅ KOL / Stakeholder Insights

✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots

✅ Market Volatility & Emerging Risks Analysis

✅ Quarterly Industry Report Updated

✅ Live Market & Pricing Trends

✅ Import-Export Data Monitoring

☛ Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?Juli

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.